Results 101 to 110 of about 21,874 (160)

Targeted Therapies for Each Subtype of Breast Cancer. [PDF]

MedComm (2020)
Liu A, Peng P, Zhu Y, Fei Q, Liu W, Zhang S.   +5 more
europepmc   +1 more source

Disrupting DDB2-DNA Interaction by Lapatinib Enhances Chemotherapy Sensitivity. [PDF]

Int J Biol Sci
Hsu SC, He YH, Chen YJ, Le UNP, Liu PT, Huynh TK, Chen YL, Wei YL, Chou HC, Huang WC, Jeng LB.   +10 more
europepmc   +1 more source

Actions of Midostaurin as Cation Channel and Tyrosine Kinase Inhibitor in Diffuse Intrinsic Pontine Glioma Cell Lines. [PDF]

Cancers (Basel)
Antonacci M, Di Turi A, Miciaccia M, Denora M, Maqoud F, Perrone MG, Scilimati A, Tricarico D.   +7 more
europepmc   +1 more source

[Retracted] EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P‑gp substrates <i>in vitro</i> and <i>in vivo</i>. [PDF]

Oncol Rep
Jin Y, Zhang W, Wang H, Zhang Z, Chu C, Liu X, Zou Q.   +6 more
europepmc   +1 more source

In Silico Molecular Docking and Pharmacokinetic Evaluation of Cannabinoid Derivatives as Multi-Target Inhibitors for EGFR, VEGFR-1, and VEGFR-2 Proteins. [PDF]

Curr Issues Mol Biol
Ayoobi A, Choi HW.
europepmc   +1 more source

Structural and Dynamic Insights into Podocalyxin-Ezrin Interaction as a Target in Cancer Progression. [PDF]

J Xenobiot
Milutinovic M, Lutimba S, Mansour MA.
europepmc   +1 more source

Trastuzumab Resistance, a Potential Roadblock for Most Successful Therapy of Breast Cancer-An Updated Review of Underlying Mechanisms, Clinical Trials and Patents to Evade the Resistance. [PDF]

Pharmaceutics
Hasan G, Pramanik S, Singh S, Gurav P, Penumaka SM, Kumar S, Mandal D.   +6 more
europepmc   +1 more source

Retraction Note: Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. [PDF]

Breast Cancer Res
Formisano L, Nappi L, Rosa R, Marciano R, D'Amato C, D'Amato V, Damiano V, Raimondo L, Iommelli F, Scorziello A, Troncone G, Veneziani BM, Parsons SJ, De Placido S, Bianco R.   +14 more
europepmc   +1 more source